Methods of treating ptsd and neurological disorders
AssigneeGATC Health Corp
InventorsIan JENKINS, Robert TINDER, Vaishnavi NARAYAN, Noah TIPPETTS, Saman MIRZAEI, Patrick C. LILLEY, Gwendelyn C. LILLEY, Jayson UFFENS
Life of this patent
Estimating the term…
Abstract
Embodiments include therapeutic small molecules for use in treating addiction and neurological disorder by stimulating neuroplasticity. The therapeutic small molecule can increase neuroplasticity and improve neural function by affecting upstream regulators of FOS, JUN, BDNF, CDC42 and CCL2. The therapeutic small molecule can also aid in reduction of Amyloid plaques via binding with amyloid beta (a4).
Claims12
A compound of Formula A1, B1, C1, D1, E1, F1, G1, H1, A2, B2, C2, D2, E2, F2, G2, H2, A3, B3, C3, D3 and E3, or an analog thereof:
A method of treating an ailment comprising administration of an effective amount of the compound of Formula A1, B1, C1, D1, E1, F1, G1, H1, A2, B2, C2, D2, E2, F2, G2, H2, A3, B3, C3, D3, E3 or an analog thereof.
A method of increasing neuroplasticity or improving neural function to treat an ailment in a subject in need thereof, the method comprising administering of the compound of A1, B1, C1, D1, E1, F1, G1, H1, A2, B2, C2, D2, E2, F2, G2, H2, A3, B3, C3, D3, E3 or an analog thereof.
-15. (canceled)
-22. (canceled)
Dependencies are inferred from the claim text.